CRP and pulmonary emphysema: Based on the literature, we evaluated the efficacy of five biomarkers - sRAGE, SP-D, fibrinogen, CC16, and CRP - both individually and in combination, at predicting airflow limitation, severity of emphysema, exacerbations, decline in FEV1, progression of emphysema, and mortality in the COPDGene and ECLIPSE cohorts.